Kai Zeng

Key Laboratory Of Cell Biology, Ministry Of Public Health And Key Laboratory Of Medical Cell Biology
Shenyang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Nucleic sexual hormone receptor signaling pathways in breast cancer: function regulation, crosstalk, and therapeutic implications.

Nucleic sexual hormone receptor signaling pathways in breast cancer: function regulation, crosstalk, and therapeutic implications.

Journal: NPJ precision oncology
Published: January 06, 2026

KDM4B modulates ERα signaling pathway to participate in vascular smooth muscle cell calcification.

KDM4B modulates ERα signaling pathway to participate in vascular smooth muscle cell calcification.

Journal: Cell death discovery
Published: May 05, 2025

The chromatin remodeling factor BAP18 promotes non-small cell lung cancer progression via the recruitment of β-catenin with the transcriptional coactivator complex ACTL6A-PAF1.

The chromatin remodeling factor BAP18 promotes non-small cell lung cancer progression via the recruitment of β-catenin with the transcriptional coactivator complex ACTL6A-PAF1.

Journal: The Journal of biological chemistry
Published: December 28, 2024

MRPL13 enhances mitochondrial function and promotes tumor progression in ovarian cancer by inhibiting mPTP opening via SLC25A6.

MRPL13 enhances mitochondrial function and promotes tumor progression in ovarian cancer by inhibiting mPTP opening via SLC25A6.

Journal: Cell death & disease
Published: December 12, 2024

RBAP48 facilitates the oral squamous cell carcinoma process in an androgen receptor-dependent and independent manners.

RBAP48 facilitates the oral squamous cell carcinoma process in an androgen receptor-dependent and independent manners.

Journal: Communications biology
Published: December 17, 2023

BAP18 acting as a novel peroxisome proliferator-activated receptor α co-regulator contributes to hepatocellular carcinoma progression.

BAP18 acting as a novel peroxisome proliferator-activated receptor α co-regulator contributes to hepatocellular carcinoma progression.

Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: July 31, 2023

Knowledge graph construction based on granulosa cells transcriptome from polycystic ovary syndrome with normoandrogen and hyperandrogen.

Knowledge graph construction based on granulosa cells transcriptome from polycystic ovary syndrome with normoandrogen and hyperandrogen.

Journal: Journal of ovarian research
Published: April 02, 2023

MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer.

MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer.

Journal: EMBO molecular medicine
Published: March 07, 2023

High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer.

High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer.

Journal: Acta biochimica et biophysica Sinica
Published: July 15, 2022

BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer.

BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer.

Journal: Cell death and differentiation
Published: July 15, 2022

Ubiquitin-specific peptidase 14 maintains estrogen receptor α stability via its deubiquitination activity in endometrial cancer.

Ubiquitin-specific peptidase 14 maintains estrogen receptor α stability via its deubiquitination activity in endometrial cancer.

Journal: The Journal of biological chemistry
Published: May 24, 2022

RNF8 up-regulates AR/ARV7 action to contribute to advanced prostate cancer progression.

RNF8 up-regulates AR/ARV7 action to contribute to advanced prostate cancer progression.

Journal: Cell death & disease
Published: August 09, 2021
Showing 1-12 of 24

Last Updated: 09/26/2026